Screener
Polaryx Therapeutics, Inc. PLYX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q1 '25 | Q4 '24 | Q3 '24 | ||
|---|---|---|---|---|---|---|
| -$2.54M+49.6% | —— | -$5.05M+33.4% | -$7.59M— | -$7.59M— | ||
| $467K-89.5% | —— | $4.45M+642% | $600K— | $600K— | ||
| -$2.06M-191% | —— | -$709K-10.2% | -$643.25K— | -$643.25K— | ||
| —— | —— | $250K-86.1% | $1.8M— | $1.8M— | ||
| -206,300,000%-160,400,000% | 52,200,000%-409,700,000% | -45,900,000%— | 461,900,000%— | —— |
FAQ
- How much cash does Polaryx Therapeutics, Inc. generate?
- Polaryx Therapeutics, Inc. (PLYX) generated -$4.1M in operating cash flow over the trailing twelve months.
- Where does Polaryx Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Polaryx Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.